Complete clinical trials solution company, Hawthorne Effect, announced today (October 10) announced it had successfully recruited more than 1,000 patients in 48 states plus Hawaii for a study to qualify the prevalence of valvular heart disease (VHD).
Hawthorne Effect raises $20M with plans to disrupt the decentralized clinical trial space mobihealthnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mobihealthnews.com Daily Mail and Mail on Sunday newspapers.
Northpond Ventures, SignalFire and P5 Health Ventures have helped San Francisco-based clinical trial software firm Hawthorne Effect complete a $20 million first formal funding round.